Topic:

Emerging Markets

Latest Headlines

Latest Headlines

WSJ: Pfizer poised to sell nutrition biz to Nestlé for $9B-plus

Besides Nestlé, Pfizer had been entertaining offers from Danone and Mead Johnson Nutrition in auctioning off the unit.

Chinese regulators freeze sales of drugs with toxic capsules

The country's drug watchdog has banned the sale of 13 drugs that are made with capsules containing toxic levels of chromium.

Osprey closes Australian IPO

Australia seems to be an increasingly popular spot for foreign devicemakers to raise funds through initial public offerings and subsequently list on that country's exchange. Following in the footsteps of GI Dynamics, U.S.-based Osprey Medical has raised $20 million Australian in its IPO and plans to list on the Australian Securities Exchange.

S. Africa ratchets up protection for domestic drugmakers

Warning to pharma companies aiming to sell key drugs in South Africa: Only domestic drugmakers need apply.

FDA panel wants U-Systems' breast ultrasound approved

An FDA advisory panel of experts recommended that regulators sign off on the company's PMA application for the equipment, which is targeted to a breast cancer screening indication.

Surya Pharmaceuticals closes 2 Indian API plants

While India is one of those countries where lots of companies are expanding drug manufacturing, it is not a guarantee that because you build, business will come.

Contract manufacturing should see a boom abroad

It may not come as a surprise to most that biotech and pharma companies are expected to acquire more contract manufacturing organizations in the near future...

Malaysian generics maker in talks to buy manufacturing facility in Indonesia

Yusoff Rahman, CEO of generic drug manufacturer Pharmaniaga, confirmed the company has set aside $10 million to acquire an API plant in Indonesia.

Reactions to poor practices, 'Dateline' special on CROs differ in India

After a 'Dateline' special painted an unflattering picture of clinical research trials in India, reactions from officials there have ranged between extremes.

India considers track and trace system to combat counterfeiters

Trying to get a handle on counterfeit drugs manufactured in India, a task force is suggesting the government establish a "track and trace" system.